Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Biobanking Market Size to Reach USD 67.90 Billion in 2030 | Increase in Research Activities for Regenerative Medicines, Stem Cell Therapeutics and Cell and Gene Therapy are Key Factors Driving Industry Demand, According to Emergen Research

This image opens in the lightbox

News provided by

Emergen Research

07 Feb, 2022, 13:00 GMT

Share this article

Share toX

Share this article

Share toX

VANCOUVER, BC, Feb. 7, 2022 /PRNewswire/ -- The global biobanking market size was USD 29.79 Billion in 2020. Increasing need for genetic testing and personalized medicine are key factors driving global market revenue growth. Biobanks play a crucial role in biomedical research. Biobanks not only speed up the process of transfer of scientific knowledge into technical applications, but also give rise to situations, where obtaining such knowledge is dependent mainly on technology.

Drivers: Increased application in clinical and scientific research

Biobanks are an important resource for genomics, proteomics, metabolomic research, molecular epidemiology, translational studies, and therapeutic target creation. Thus, academic and industry researchers are showing increased interest in biobanking. Biobanking is gaining traction in the field of biomedical research. Several biobanks across the globe are assisting in medical research and clinical trials of personalized medicine as they aid in identification of biomarkers and various pharmaceutical treatments.

Get Free Sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/926

Restraints: Issues related to procurement of samples

A key factor limiting growth of the global biobanking market is issues related with procurement of biospecimen samples which is a complex procedure and involves complications and processes to be fulfilled. Moreover, biobanking equipment are expensive and this limits adoption in some developing countries.

Growth Projections

The global biobanking market size is expected to reach USD 67.90 Billion in 2030 and register a revenue CAGR of 8.6% over the forecast period. Increased focus on regenerative medicine for treatment of cancer, diabetes, Alzheimer's Disease, and other rare genetic diseases is driving biobanking market revenue growth. Umbilical cords and stem cells are preserved in biobanks to help in development of regenerative medicines and the trend is gaining traction currently.

COVID-19 Direct Impacts

Biobanking market registered significant growth during the COVID-19 pandemic as researchers stored numerous samples of bronchioalveolar lavage, oropharyngeal/ nasopharyngeal swabs, blood, sputum, urine, and stool of infected patients. The samples were collected and archived for future use to develop diagnostics, therapies, and vaccines. COVID-19 biorepositories in India alone collected over 40,000 samples for researchers to develop vaccines/therapies.

Current Trends and Innovations

Biobanks has entered the Big Data era with advancements in Artificial Intelligence (AI)-driven data analytics, process automation, robotics, and other technological advancements. This has resulted in higher quality biobanking data and contribute to a shift to data driven science. Well processed Big Data allow collaboration of biobanks in different regions and with advanced technology, these data can be handled easily. Storage option on cloud also helps resolve limited local storage capacity issue.

Geographical Outlook

Market in North America accounted for largest revenue share in 2020 due to advancements in drug discovery and increased investment in personalized and regenerative medicine. Increasing prevalence of cancer, cardiovascular, and infectious diseases is boosting growth of the market in the region. Large number of clinical trials related to COVID-19 and increasing usage of stem cell therapies for treatment of various chronic diseases is also driving market growth.

Looking for Discount on Biobanking market report [Click Here]@ https://www.emergenresearch.com/request-discount/926

Strategic Initiatives

In July 2021, BioIVT, which is a U.S.-based provider of research and high-quality biological specimens and value-added services, acquired Tissue Solutions Ltd., which is a virtual biobank in the U.K. The acquisition will add 150 collection sites to BioIVT's network, giving access to high-quality control and disease state biospecimen. It will also help in expanding skin product offerings for in-vitro models.

Some Key Highlights From the Report

  • Human tissue segment is expected to register a rapid revenue growth rate during the forecast period owing to large number of biobanks with facilities to store tissues, availability of samples and advanced technology for storage and retrieval of stored tissues. Increased investment in disease specific R&D is expected to propel demand for diseased tissues associated with myeloma, leukemia, lymphoma, prostate and lung, among other for oncology studies.
  • Clinical research segment is expected to register a rapid revenue growth rate during the forecast period, attributed to rising demand for bio-samples for drug testing in clinical research. Increase in number of COVID-19 cases across the globe has resulted in high demand for vaccine development. Governments in developing countries are also investing in clinical trials, which is further contributing to revenue growth of this segment.
  • Biobank software helps biobanks to manage samples and metadata, automate and streamline workflows, locate stored samples, and remove data silos. Biobank software can be accessed anywhere, anytime and enable biorepositories to scale up and automate operations without having to invest in IT infrastructure.
  • Some major companies included in the market report are U.K. Biobank Limited, Medizinische Universitat Graz, Hamilton Company, ASKION, Azenta Life Sciences, Qiagen, Promega Corporation, Integrated Biobank of Luxembourg (IBBL), Isenet Biobanking, and Thermo Fisher Scientific, Inc.

Explore Complete Report Description and Table of Contents of Biobanking Market Report@ https://www.emergenresearch.com/industry-report/biobanking-market

Emergen Research has segmented the global biobanking market on the basis of product & services, sample type, storage type, application, and region:

  • Product & Services Outlook (Revenue, USD Billion; 2018–2030)
    • Equipment
        1. Storage Equipment
        2. Sample Transport Equipment
        3. Sample Processing Equipment
        4. Sample Analysis Equipment
    • Consumables
        1. Collection Consumables
        2. Storage Consumables
        3. Processing Consumables
        4. Analysis Consumables
    • Services
        1. Supply Services
        2. Processing Services
        3. Storage Services
        4. Transport Services
    • Software
  • Sample Type Outlook (Revenue, USD Billion; 2018–2030)
    • Biological Fluids
    • Human Tissues
    • Blood Products
    • Nucleic Acids
    • Human Waste Products
    • Cell Lines
  • Storage Type Outlook (Revenue, USD Billion; 2018–2030)
    • Automated Storage
    • Manual Storage
  • Application Outlook (Revenue, USD Billion; 2018–2030)
    • Regenerative Medicine
    • Life Science Research
    • Clinical Research

Buy Your Exclusive Copy@ https://www.emergenresearch.com/select-license/926

  • Regional Outlook (Revenue, USD Billion; 2018–2030)
    • North America
        1. U.S.
        2. Canada
        3. Mexico
    • Europe
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Sweden
        7. BENELUX
        8. Rest of Europe
    • Asia Pacific
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Rest of APAC
    • Latin America
        1. Brazil
        2. Rest of LATAM
    • Middle East & Africa
        1. Saudi Arabia
        2. UAE
        3. South Africa
        4. Israel
        5. Rest of MEA

Want to Explore Complete Table of Content (TOC) for Biobanking Market[Click Here]@ https://www.emergenresearch.com/industry-report/biobanking-market/toc

Latest Published Reports by Emergen Research in Healthcare And Pharmaceuticals Industry Segment:

Targeted Therapeutics Market, By Therapy (Monoclonal Antibodies, Small Molecule Inhibitors), By Disease Indication, By End-use, and By Region Forecast to 2028.

Dermal Regeneration Template Market By Type (Fortified Type, Fenestrated Type, Single Layer Type), By Application (Massively Burned Patients, Acutely Excised Wounds, Chronic Wounds, Others), By End Use (Hospital, Wound Care, Others) By Region Forecast to 2028.

Telehealth Market, By Type (Tele-Home and Tele-Hospital), By Component, By Deployment Model (Web & Cloud-based and On-premises), By Application, By End-user, and By Region Forecast to 2028.

Augmented Reality and Virtual Reality in Healthcare Market By Technology (Augmented Reality, Virtual Reality), By Component (Hardware, Software, Services), By Application (Surgery, Training & Education), By End-use (Hospitals, Clinics), and By Region Forecast to 2030.

Leadless Pacemaker Systems Market, By Product Type, By Application (Atrial Fibrillation, Sinus Node Dysfunction, Atrioventricular Block and Others), By Technology, By End-use, and By Region Forecast to 2028.

Biodefense Market Size, Share, Trends, By Product Type (COVID-19 Vaccine, Anthrax Vaccine, Others), By Biothreat Detection Device Type, By End-Use, and By Region Forecast to 2028.

Cryotherapy Market By Product (Localized Cryotherapy Devices, Cryosurgery Devices, Cryochambers & Cryosaunas, Gas Cylinders, Others), By Therapy (Icepack Therapy, Cryosurgery, Chamber Therapy), By Application, By End-Use, and By Region Forecast to 2028

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com  
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com  
Visit for More Insights: https://www.emergenresearch.com/insights  
Explore Our Custom Intelligence services | Growth Consulting Services 
Read our Press Release on Biobanking @ https://www.emergenresearch.com/press-release/global-biobanking-market

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.